Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy.

Van Vickle GD, Esh CL, Daugs ID, Kokjohn TA, Kalback WM, Patton RL, Luehrs DC, Walker DG, Lue LF, Beach TG, Davis J, Van Nostrand WE, Castaño EM, Roher AE.

Am J Pathol. 2008 Aug;173(2):483-93. doi: 10.2353/ajpath.2008.071191. Epub 2008 Jul 3.

2.

Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.

Kumar-Singh S.

Int J Mol Sci. 2009 Apr 23;10(4):1872-95. doi: 10.3390/ijms10041872. Review.

3.

APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.

Crews L, Rockenstein E, Masliah E.

Brain Struct Funct. 2010 Mar;214(2-3):111-26. doi: 10.1007/s00429-009-0232-6. Epub 2009 Nov 29. Review.

4.
5.

Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

Wisniewski T, Boutajangout A.

Brain Struct Funct. 2010 Mar;214(2-3):201-18. doi: 10.1007/s00429-009-0236-2. Epub 2009 Dec 10. Review.

6.

Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies.

Hiltunen M, van Groen T, Jolkkonen J.

J Alzheimers Dis. 2009;18(2):401-12. doi: 10.3233/JAD-2009-1154. Review.

PMID:
19584429
7.

Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

Puzzo D, Arancio O.

J Alzheimers Dis. 2013;33 Suppl 1:S111-20. Review.

8.

Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease.

Thal DR, Griffin WS, Braak H.

J Cell Mol Med. 2008 Oct;12(5B):1848-62. doi: 10.1111/j.1582-4934.2008.00411.x. Epub 2008 Jul 10. Review.

9.
10.

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.

Weller RO, Boche D, Nicoll JA.

Acta Neuropathol. 2009 Jul;118(1):87-102. doi: 10.1007/s00401-009-0498-z. Epub 2009 Feb 22. Review.

PMID:
19234858
11.

Animal models of cerebral amyloid angiopathy.

Jäkel L, Van Nostrand WE, Nicoll JAR, Werring DJ, Verbeek MM.

Clin Sci (Lond). 2017 Sep 28;131(19):2469-2488. doi: 10.1042/CS20170033. Print 2017 Oct 15. Review.

PMID:
28963121
12.

Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.

Glabe C.

J Mol Neurosci. 2001 Oct;17(2):137-45. Review.

PMID:
11816787
13.

A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease.

Bayer TA, Schäfer S, Breyhan H, Wirths O, Treiber C, Multhaup G.

Clin Neuropathol. 2006 Jul-Aug;25(4):163-71. Review.

PMID:
16866297
14.

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders.

Batarseh YS, Duong QV, Mousa YM, Al Rihani SB, Elfakhri K, Kaddoumi A.

Int J Mol Sci. 2016 Mar 4;17(3):338. doi: 10.3390/ijms17030338. Review.

15.

Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease.

Oh ES, Troncoso JC, Fangmark Tucker SM.

Neuromolecular Med. 2008;10(3):195-207. doi: 10.1007/s12017-008-8035-0. Epub 2008 Jun 10. Review.

16.

Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Kokjohn TA, Maarouf CL, Roher AE.

Alzheimers Dement. 2012 Nov;8(6):574-83. doi: 10.1016/j.jalz.2011.05.2429. Epub 2011 Nov 2. Review.

17.

How to get from here to there: macrophage recruitment in Alzheimer's disease.

Rezai-Zadeh K, Gate D, Gowing G, Town T.

Curr Alzheimer Res. 2011 Mar;8(2):156-63. Review.

18.

T-cells in Alzheimer's disease.

Town T, Tan J, Flavell RA, Mullan M.

Neuromolecular Med. 2005;7(3):255-64. Review.

PMID:
16247185
19.

Cholesterol: from heart attacks to Alzheimer's disease.

Raffai RL, Weisgraber KH.

J Lipid Res. 2003 Aug;44(8):1423-30. Epub 2003 Jul 1. Review.

20.

Beta-amyloid, blood vessels, and brain function.

Smith EE, Greenberg SM.

Stroke. 2009 Jul;40(7):2601-6. doi: 10.1161/STROKEAHA.108.536839. Epub 2009 May 14. Review.

Supplemental Content

Support Center